Related Experiment Video

Updated: Jun 22, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Delayed development of a biloma in an infant following hepatic injury

T I Anatol1, P Maharaj, S Gardner

  • 1Department of Clinical Surgical Sciences, Faculty of Medical Sciences, St Augustine, The University of the West Indies, Trinidad and Tobago, West Indies. trevana@wow.net

The West Indian Medical Journal
|July 2, 2009
PubMed

Insights

A rare case of infant biloma formation is reported three months post-hepatic injury. This delayed presentation occurred after significant healing, highlighting unusual clinical timelines in pediatric liver trauma.

Area of Science:

  • Pediatric Surgery
  • Hepatobiliary Medicine
  • Trauma Surgery

Background:

  • Hepatic injuries in infants can lead to complications.
  • Bilomas are collections of bile that can form after liver trauma.
  • Delayed complications are less common but clinically significant.

Purpose of the Study:

  • To report a unique case of delayed biloma formation in an infant.
  • To review the literature on unusual presentations of post-traumatic bilomas.
  • To emphasize the importance of monitoring after major hepatic injury.

Main Methods:

  • Case presentation of an infant with delayed biloma.
  • Review of relevant medical literature on pediatric bilomas and hepatic injuries.
  • Analysis of clinical course and management.

Main Results:

  • An infant developed a biloma three months after a major hepatic injury.
  • The biloma appeared after the initial injury had almost completely healed.
  • Literature review identified this presentation as unusual.

Conclusions:

  • Delayed biloma formation is a rare but possible complication following pediatric hepatic injury.
  • Close monitoring is essential even after apparent healing of liver trauma.
  • Further research into the pathophysiology of delayed biloma formation is warranted.

More Related Videos

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration05:37

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates06:10

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...